Find Therapeutics, a new drug development company dedicated to breakthrough therapies against rare diseases launches in Montreal

Read Article

Pfizer Acquires Clinical-Stage Biotech Therachon

Read Article

Zymeworks Reports IND-Submission Milestone Achieved in Lilly Collaboration

Read Article

Immunovaccine Inc. Has Applied to List its Common Shares on Nasdaq, Announces Reverse Stock Split

Read Article

Zymeworks Presents Results of the Completed Dose Escalation Portion of the Ongoing Phase 1 Study of ZW25 at the San Antonio Breast Cancer Symposium

Read Article

Zymeworks Announces License Agreement with Johnson & Johnson Innovation to Develop and Commercialize Next Generation Bispecific Antibody Therapeutics

Read Article

PreciThera, Inc. Completes $36M Series A Financing

Read Article

Zymeworks Announces Pricing of Initial Public Offering

Read Article

Immunovaccine Announces Positive Interim Clinical Data from Ovarian Cancer Study of DPX

Read Article

SutroVax Announces Closing of $64M via Series B Financing

Read Article

CellAegis Devices Announces US$9.5 Million Financing to Support Clinical and Regulatory Advancement of its autoRIC® Device

Read Article

Profound Medical Corp. Completes Previously Announced $17.4M Bought Deal Offering of Common Shares

Read Article

Toronto’s Xagenic Inc. completes successful beta testing of X1 diagnostic system

Read Article

Immunovaccine’s Preclinical DPX-NEO Program Demonstrates Positive Anti-Cancer Activity

Read Article

Venous infers_Early work sufficient to attract $21M for Ilkos leg ulcers effort

Read Article

Immunovaccine Announces Closing of $8M Bought Deal Private Placement Financing

Read Article

Zymeworks and GSK Enter Second Strategic Collaboration to Develop and Commercialize Bi-Specific Antibodies

Read Article

Zymeworks Names Diana Hausman, M.D. Chief Medical Officer

Read Article

DalCor raises $100M in series B

Read Article

Biotech upstart gambles $150M believing it can succeed after Big Pharmas failed on CETP

Read Article